Wang et al. reported that treatment with a combination of BCG and anti-PD-L1 resulted in an enhanced anti-tumor effect in an orthotopic rat bladder cancer model by reducing tumor burden and prolonging survival. This evidence concerns the gene CD274 and urinary bladder carcinoma.